What we do JFL Life Sciences Ltd manufactures and markets pharmaceutical products including dry powder injections, tablets, capsules, and oral rehydration solutions, serving global markets. |
Founded in 2,010 |
Market share Exports to African, Middle Eastern, and CIS countries; registered in several international markets. |
Problem solved Provides essential pharmaceutical products catering to healthcare needs globally, ensuring quality and compliance. |
Top clients or who we serve B2B pharmaceutical distributors and merchant exporters in multiple international markets. |
Key management Smiral Ashwinkumar Patel (Managing Director), Tejal Smiral Patel (Whole Time Director). |
Our journey and innovations Founded in 2010; converted to public company in 2022; IPO raised Rs.18.16 cr; expanding international registrations and exports. |
Where we operate India headquarters with exports mainly to Africa, Middle East, and CIS countries. |
Top products or what we offer Dry powder injections, solid oral dosage tablets and capsules (beta-lactam and general), oral rehydration solutions. |
Top brands - |
Raw materials needed Active pharmaceutical ingredients and excipients for injections, tablets, and capsules. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue primarily from recurring pharmaceutical product sales. |
Our industry position Emerging exporter with growing international registrations and steady revenue growth. |
Financial highlights FY 2024-25 revenue Rs. 82.04 cr; net profit Rs. 4.16 cr; EPS 1.26 showing profitable growth. |
Geographical revenue split Significant exports to Africa, Middle East, and CIS regions; domestic market details not specified. |
Order book - |
Whats driving growth Market expansion, product registrations abroad, improved product quality, and customer focus. |
Our future plans Focus on sustainable growth through market exploration and product excellence enhancement. |
Our green promise - |
Our people and values Committed workforce promoting transparency, ethical governance, and a harassment-free workplace. |
Key challenges ahead Regulatory approvals, competition, international market fluctuations, and maintaining quality standards. |
Interesting facts Successfully listed in 2025; exporting to multiple emerging markets through merchant exporters. |
Risks and strategy Managing regulatory compliance risks via robust quality control and diversified export markets. |
